2017-09-08 - TRANSLATIONAL MEDICINE'17: ENHANCING PREDICTIVITY

igen biotech will participate in the "Translational Medicine'17: Enhancing Predictivity" Conference arranged by EATRIS (September 24-26, 2017 - Prague, Czech Republic).

igen will present the case of EPiGen, a new predictive test based on IGFBP-3 biomarker, to personalize Non-Small Cell Lung Cancer Treatments.

2017-03-21 - GENYCELL BIOTECH ESPAÑA, S.L. AS SPAIN AND PORTUGAL DISTRIBUTOR

Ilab Tech formalizes a distribution agreement with Genycell Biotech España, S.L.

The supply of our kits in Spain and Portugal will  be made, exclusively for the New iGENatal  product, and not exclusively for the rest of our  catalog products, by Genycell Biotech  España,  S.L. who will answer your orders through who  will answer your orders through the email  address:

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

2015-12-04 - ILAB participates in the RETOS COLABORACION 2015 program

Ilab Tech participates in the RETOS COLABORACION 2015 program (MINECO). The consortium led by IGEN Biotech intends to carry out the development and validation of two kit prototypes to detect a biomarker that oncologists can use as an objective tool to personalize treatment in non-small cell lung cancer in advanced stages. IdiPAZ and IGEN Biotech also participate in the project. The project is funded by the Ministry of Economy and Competitiveness and funds from the European Union, within the objective of promoting the technological development, innovation and research.

MINISTRY OF ECONOMY AND COMPETITIVENESS AND EUROPEAN UNION

Promoting the technological development, innovation and research.

 

 

2015-12-04 - ILAB participates in the RETOS COLABORACION 2015 program

Ilab Tech participates in the RETOS COLABORACION 2015 program (MINECO). The consortium led by IGEN Biotech intends to carry out the development and clinical validation of a genetic or/and epigenetic biomarkers analysis system to personalize treatment in inflammatory and autoimmune diseases. The project also involved the Foundation for Biomedical Research of the University Hospital "La Princesa", the Complutense University of Madrid, Making Genetics, Ambar and IGEN Biotech. The project is funded by the Ministry of Economy and Competitiveness and funds from the European Union, within the objective of promoting the technological development, innovation and research.

MINISTRY OF ECONOMY AND COMPETITIVENESS AND EUROPEAN UNION

Promoting the technological development, innovation and research.